thallium chloride has been researched along with (dtpa-phe(1))-octreotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitakata, Y; Kuyama, J; Sakata, S; Uchida, Y; Uno, K | 1 |
| Borson-Chazot, F; Houzard, C; Sassolas, G; Sigartau, C | 1 |
1 review(s) available for thallium chloride and (dtpa-phe(1))-octreotide
| Article | Year |
|---|---|
[Tumor imaging in nuclear medicine].
Topics: Citric Acid; Gallium Radioisotopes; Gamma Cameras; Humans; Indium Radioisotopes; Neoplasms; Octreotide; Pentetic Acid; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1996 |
1 other study(ies) available for thallium chloride and (dtpa-phe(1))-octreotide
| Article | Year |
|---|---|
[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Topics: Adenocarcinoma; Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thyroid Neoplasms | 1997 |